| Pharmaceuticals from the Sea: Using marine microorganisms in unimaginable ways. CONNECT. Pharmacological research reveals that marine cyanobacteria, single-celled organisms often referred to as blue-green algae, have proven to be an effective cancer treatment in recent human clinical trials. Rapidly opening new doors for natural product drug development, cyanobacteria coupled with new screening processes and technology, is allowing for a rich interface of creative research in anticancer and anti-inflammatory activity. In this lecture, Dr. William Gerwick, Professor in the Center for Marine Biotechnology and Biomedicine, will discuss the recent discoveries being made at the Gerwick Research Laboratory. These breakthroughs will illustrate the application of techniques in the more effective investigation of marine cyanobacteria and other microalgae for pharmaceutical lead compounds as well as biofuel-relevant lipids. See http://www.connect.org |
RSS